Evidence map›Paper›PMID 35996931›Full record

ArticleJournal of Korean medical science2022

Risk of Subsequent Events in Patients With Minor Ischemic Stroke or High-Risk Transient Ischemic Attack.

Keon-Joo Lee, Dong Woo Shin, Hong-Kyun Park, Beom Joon Kim, Jong-Moo Park, Kyusik Kang, Tai Hwan Park, Kyung Bok Lee, Keun-Sik Hong, Yong-Jin Cho and 22 more

Abstract read
In one paragraph

Article in Journal of Korean medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Keon-Joo LeeDepartment of Neurology, Korea University Guro Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-6571-7091
Dong Woo ShinDepartment of Neurology, Ewha Womans University Mokdong Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-7918-3783
Hong-Kyun ParkDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-8120-2469
Beom Joon KimDepartment of Neurology and Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0002-2719-3012
Jong-Moo ParkDepartment of Neurology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Korea.ORCID https://orcid.org/0000-0002-4199-3024
Kyusik KangDepartment of Neurology, Nowon Eulji Medical Center, Eulji University, Seoul, Korea.ORCID https://orcid.org/0000-0002-4021-4439
Tai Hwan ParkDepartment of Neurology, Seoul Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-5148-1663
Kyung Bok LeeDepartment of Neurology, Soonchunhyang University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2663-7483
Keun-Sik HongDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-4684-6111
Yong-Jin ChoDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0001-6965-0771
Dong-Eog KimDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-9339-6539
Wi-Sun RyuDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-2823-5253
Byung-Chul LeeDepartment of Neurology, Hallym Neurological Institute, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-3885-981X
Kyung-Ho YuDepartment of Neurology, Hallym Neurological Institute, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-8997-5626
Mi-Sun OhDepartment of Neurology, Hallym Neurological Institute, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-6741-0464
Soo Joo LeeDepartment of Neurology, Daejeon Eulji Medical Center, Eulji University, Daejeon, Korea.ORCID https://orcid.org/0000-0001-8622-7000
Jae Guk KimDepartment of Neurology, Daejeon Eulji Medical Center, Eulji University, Daejeon, Korea.ORCID https://orcid.org/0000-0003-1418-0033
Jun LeeDepartment of Neurology, Yeungnam University Medical Center, Daegu, Korea.ORCID https://orcid.org/0000-0001-8643-0797
Jae-Kwan ChaDepartment of Neurology, Dong-A University Hospital, Busan, Korea.ORCID https://orcid.org/0000-0002-1049-5196
Dae-Hyun KimDepartment of Neurology, Dong-A University Hospital, Busan, Korea.ORCID https://orcid.org/0000-0001-9761-7792
Joon-Tae KimDepartment of Neurology, Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0003-4028-8339
Kang-Ho ChoiDepartment of Neurology, Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0001-8851-2104
Jay Chol ChoiDepartment of Neurology, Jeju National University Hospital, Jeju, Korea.ORCID https://orcid.org/0000-0002-3550-2196
Eva LesénAstraZeneca, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-2198-4382
Jonatan HedbergAstraZeneca, Gothenburg, Sweden.ORCID https://orcid.org/0000-0001-9362-4020
Amarjeet TankAstraZeneca, Cambridge, UK.ORCID https://orcid.org/0000-0002-9523-4365
Edmond G FitaAstraZeneca, Cambridge, UK.ORCID https://orcid.org/0000-0001-7265-7659
Ji Eun SongDepartment of Biostatistics, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8440-3821
Ji Sung LeeClinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8194-3462
Juneyoung LeeDepartment of Biostatistics, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8073-9304
Hee-Joon BaeDepartment of Neurology and Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Seongnam, Korea. braindoc@snu.ac.kr.ORCID https://orcid.org/0000-0003-0051-1997
CRCS-K Investigators

Funding

AstraZenecaMinistry for Health and Welfare HI10C2020Oxford PharmaGenesis
6 · The paper itself

Abstract

This study aimed to present the prognosis after minor acute ischemic stroke (AIS) or transient ischemic attack (TIA), using a definition of subsequent stroke in accordance with recent clinical trials. In total, 9,506 patients with minor AIS (National Institutes of Health Stroke Scale ≤ 5) or high-risk TIA (acute lesions or ≥ 50% cerebral artery steno-occlusion) admitted between November 2010 and October 2013 were included. The primary outcome was the composite of stroke (progression of initial event or a subsequent event) and all-cause mortality. The cumulative incidence of stroke or death was 11.2% at 1 month, 13.3% at 3 months and 16.7% at 1 year. Incidence rate of stroke or death in the first month was 12.5 per 100 person-months: highest in patients with large artery atherosclerosis (17.0). The risk of subsequent events shortly after a minor AIS or high-risk TIA was substantial, particularly in patients with large artery atherosclerosis.

Indexed as

AtherosclerosisIschemic Attack, TransientIschemic StrokeStrokeHumansRecurrenceRisk FactorsEvent OutcomeIschemic Attack, TransientMinor Ischemic StrokeStroke Recurrence

Identifiers

PMID35996931
PMCPMC9424742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.